Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Orthopedic Surgery

Background:

• Bone fracture non-union affects a significant patient fraction, often requiring surgery due to challenging molecular cause identification.
• Current treatments for non-union fractures are primarily surgical, highlighting a need for better molecular understanding and targeted therapies.

Purpose of the Study:

• To generate a transcriptional atlas of human osteoprogenitor cells from healing callus and non-union fractures.
• To compare gene expression and functional osteogenic potential between healing callus, non-union fractures, and marrow bone.
• To identify molecular regulators, such as FOS, involved in non-union fracture development.

Main Methods:

• Generated transcriptional atlases of human osteoprogenitor cells from three distinct bone conditions: marrow bone, healing callus, and non-union fractures.
• Performed detailed gene expression analysis and functional assays to assess osteogenic potential.
• Utilized longitudinal transcriptional profiling and validated findings in a cohort of 31 tissue samples.

Main Results:

• Osteoprogenitor cells from healing callus and non-union fractures showed significant gene expression similarity but distinct functional osteogenic potential.
• Longitudinal transcriptional profiling identified FOS as a putative master regulator of non-union fractures.
• Validation in a cohort confirmed FOS activity, supporting its role in non-union pathogenesis.

Conclusions:

• Identified novel molecular targets for non-union fracture classification and treatment.
• Characterized FOS as a key regulator in human non-union fractures.
• Provided a valuable resource for understanding human bone healing biology and developing new therapeutic strategies.